| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 10%+ Owner | Feb 12, 2024 | |||
| Brian L. Kotzin | Director | Feb 7, 2024 | |||
| James Bum Chung | Chief Medical Officer | Feb 7, 2024 | |||
| Karen Walker | Chief Technology Officer | Jun 6, 2024 | |||
| Northpond Ventures III GP, LLC | Former 10% Owner | Feb 12, 2024 | |||
| Bain Capital Life Sciences Investors, LLC | 10%+ Owner | Feb 12, 2024 | |||
| Westlake BioPartners Fund I, L.P. | 10%+ Owner | Feb 12, 2024 | |||
| Peter Maag | Chief Executive Officer, Director | Feb 7, 2024 | |||
| Beth C. Seidenberg | Director, 10%+ Owner | Feb 12, 2024 | |||
| Ryan Jones | Chief Financial Officer | May 28, 2024 | |||
| Vida Ventures, LLC | 10%+ Owner | Feb 12, 2024 | |||
| Fred E. Cohen | Director, 10%+ Owner | Feb 12, 2024 | |||
| Ian T. Clark | Director | Feb 7, 2024 | |||
| Dominique Christian Borie | President, Research and Development Exhibit 24 - Power of Attorney | Feb 7, 2024 | |||
| Daniel K. Spiegelman | Director | Feb 7, 2024 | |||
| Stephen Constantine Liapis | Director | Feb 7, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|